Dorin Toader

1.7k citations

44 papers · 1.0k indexed · h-index 16

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research
Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research

Papers in

Organic Chemistry 26
- Chemical Synthesis and Reactions 5
- Click Chemistry and Applications 4
- Synthetic Organic Chemistry Methods 4
Oncology 14
- HER2/EGFR in Cancer Research 8

Co-authors: Alan R. Katritzky Linghong Xie Andrew D. Ferguson Richard A. Norman Jamal Saeh Changshou Gao Jon Read Ryan Fleming
Journals: The Journal of Organic Chemistry (8 papers)Cancer Research (6 papers)Journal of Medicinal Chemistry (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of the American Chemical Society (2 papers)
Partner nations: United States United Kingdom Poland

In The Last Decade

Dorin Toader

42 papers receiving 972 citations

Peers

Countries citing papers authored by Dorin Toader

Since Specialization

Citations

This map shows the geographic impact of Dorin Toader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorin Toader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorin Toader more than expected).

Fields of papers citing papers by Dorin Toader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorin Toader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorin Toader. The network helps show where Dorin Toader may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dorin Toader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dorin Toader Line = papers co-authored together Dorin Toader links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PBPK Modeling to Predict Clinical Drug–Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F‐Hydroxypropylamide CPT Pharmacometrics & Systems Pharmacology ·Niyanta Kumar, Vaishali Dixit, Howard Burt, Katherine L. Gill, Hannah M. Jones, Natalie Keirstead, Dian Su, Dorin Toader, Timothy B. Lowinger	2025	0
2	Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates Molecular Cancer Therapeutics ·Joshua D. Thomas, M. Mantegazza, Mao Yin, Natalya D. Bodyak, Jephthah O. Osei, Marina Protopopova, B Rzegocinska-Tyzuk, Brian Jones, Liping Yang, Daniel Custar, Carlos González Baez, Damon R. Demady, Scott D. Collins, Ling Xu, A.L. Aspler, LiuLiang Qin, Elena Ter‐Ovanesyan, Marc Damelin, Dorin Toader, Timothy B. Lowinger	2024	0
3	Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses Nature Communications ·純一平野, Travis Monnell, Anette Iff, Pamela Shaw, R Lelandais, Carlos González Baez, Melissa Dolan, Rebecca Mosher, Mk., Chen‐Ni Chin, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Timothy B. Lowinger, Marc Damelin	2024	33
4	Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates Journal of Medicinal Chemistry ·Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid, Carlos González Baez, K. W. Bentley, Scott D. Collins, Timothy K. Eitas, Brian Jones, B Rzegocinska-Tyzuk, R Lelandais, Marina Protopopova, Soumya S. Ray, Elena Ter‐Ovanesyan, Ling Xu, Liping Yang, 掛見喜一郎, Marc Damelin, Dorin Toader, Timothy B. Lowinger	2023	32
5	Abstract 2114: Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells Cancer Research ·Naniye Mallı Cetinbas, Carlos González Baez, Travis Monnell, Anette Iff, K. W. Bentley, Susan M. Clardy, 김성준, 久雄伊藤, Marina Protopopova, Charles Dormoy, Joshua D. Thomas, Dea Levana, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	2022	6
6	620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates SHILAP Revista de lepidopterología ·Naniye Mallı Cetinbas, Travis Monnell, Winnie Lee, Carlos González Baez, Chen‐Ni Chin, Pamela Shaw, Kelly L. Slocum, LiuLiang Qin, Y. Liu, K. W. Bentley, Susan M. Clardy, Brian Jones, B Rzegocinska-Tyzuk, Joshua D. Thomas, Rebecca Mosher, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	2020	3
7	Abstract 232: An antibody-drug conjugate carrying a microtubule inhibitor and a DNA alkylator exerts both mechanisms of action on tumor cells Cancer Research ·Jeremy R. Duvall, Marc Damelin, B.A. Sastry, Barrett J. Nehilla, Marina Protopopova, Patrick R. Conlon, LiuLiang Qin, Charles Bodart, Jamie Johnson, Qingxiu Zhang, Dorin Toader, Timothy B. Lowinger	2019	4
8	Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates ACS Medicinal Chemistry Letters ·Pamela Thompson, William Vaughan Simpkinson, Ian Hutchinson, Ryan Fleming, Binyam Bezabeh, Jack Ridderhof, Shenlan Mao, Cui Chen, Luke A. Masterson, Haihong Zhong, Dorin Toader, Philip W. Howard, Herren Wu, Changshou Gao, Nazzareno Dimasi	2016	28
9	A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy Cancer Cell ·Brian S. Whitehouse, Samuel R. Perry, Vanessa Muniz‐Medina, Xinzhong Wang, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Hinrichs, Binyam Bezabeh, Ryan Fleming, Nazzareno Dimasi, Hui Feng, Dorin Toader, Andy Q. Yuan, Lan Xu, Jia Lin, Changshou Gao, Herren Wu, Rakesh Dixit, Jane Osbourn, Steven Coats	2016	292
10	Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol ACS Chemical Biology ·Jiaquan Wu, Francoise Powell, Nicholas Larsen, Zhongwu Lai, Dzhanan Sherif, Jon Read, Rong-Fang Gu, Mark J. Roth, Dorin Toader, Jamal Saeh, Huawei Chen	2012	118
11	Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Vibha Oza, Susan Ashwell, Patrick Brassil, J. Breed, Juliet Ngozi O. Oka, Chun Deng, Michael Grondine, Candice L. Horn, Marine Souto Alves, Paul D. Lyne, Nicholas J. Newcombe, Martin Pass, Jon Read, Mei Su, Dorin Toader, Dingwei Yu, Yan Yu, Sonya Zabludoff	2012	19
12	Structural approaches to obtain kinase selectivity Trends in Pharmacological Sciences ·Richard A. Norman, Dorin Toader, Andrew D. Ferguson	2012	58
13	Structure-based design of protein tyrosine phosphatase-1B inhibitors Bioorganic & Medicinal Chemistry Letters ·Emma Black, J. Breed, Alexander L. Breeze, Kevin J. Embrey, Robert Garcia, Thomas W. Gero, Bismark Kofi Meisuh, Peter W. Kenny, Andrew Morley, Claire A. Minshull, Andrew Pannifer, Jon Read, Amanda Rees, Daniel Russell, Dorin Toader, Julie A. Tucker	2005	60
14	The Preparation of Mono-, 1,1-Di-, trans-1,2-Di- and Trisubstituted Ethylenes by Benzotriazole Methodology Synlett ·Alan R. Katritzky, Dorin Toader	2001	2
15	Reactions of 1-(Benzotriazol-1-yl)-1-phenoxyalkane and (Benzotriazol-1-yl)ethoxyphenylmethane Anions with Nitroarenes: a New Approach to Alkyl and Aryl p-Nitroaryl Ketones Journal of Chemical Research Synopses ·Alan R. Katritzky, Christophe Chassaing, Dorin Toader, Manel MAAZOUN	1999	4
16	Novel Syntheses of 1,2-Diarylprop-2-en-1-ones The Journal of Organic Chemistry ·Alan R. Katritzky, Dorin Toader, Christophe Chassaing	1998	4
17	First General Synthesis of (p-Nitroaryl)diarylmethanes via Vicarious Nucleophilic Substitution of Hydrogen The Journal of Organic Chemistry ·Alan R. Katritzky, Dorin Toader	1997	55
18	General and Efficient Insertions of Carbons Carrying Aryl and Heteroaryl Groups: Synthesis of α-Aryl- and α-Heteroaryl-Substituted Ketones The Journal of Organic Chemistry ·Alan R. Katritzky, Dorin Toader, Linghong Xie	1996	27
19	General and Efficient Carbon Insertion Route to One-Carbon-Homologated .alpha.-Aryl, .alpha.-Alkenyl, .alpha.-Alkoxy, and .alpha.-Phenylthio Alkyl Ketones Journal of the American Chemical Society ·Alan R. Katritzky, Linghong Xie, Dorin Toader, Vugar Abudlayev	1995	33
20	Synthesis of Pyrylium Salts with Various Anions Bulletin des Sociétés Chimiques Belges ·Zhenyu Wu, T. S. Balaban, Acce, Dorin Toader, A. T. Balaban	1991	7

About Dorin Toader

Dorin Toader is a scholar working on Organic Chemistry, Oncology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Chemical Synthesis and Analysis (7 papers), interferon and immune responses (5 papers), Chemical Synthesis and Reactions (5 papers), Click Chemistry and Applications (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (296 citations), Oncology (345 citations), Organic Chemistry (327 citations), Immunology (179 citations) and Toxicology (22 citations). Dorin Toader has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Alan R. Katritzky, Linghong Xie, Andrew D. Ferguson, Richard A. Norman, Jamal Saeh, Changshou Gao, Jon Read, Ryan Fleming, Herren Wu and Binyam Bezabeh. Their work appears in journals such as The Journal of Organic Chemistry, Cancer Research, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact